Latest Breaking News On - Sangamo therapeutic - Page 1 : vimarsana.com

US$3 50 - That s What Analysts Think Sangamo Therapeutics, Inc (NASDAQ:SGMO) Is Worth After These Results

US$3 50 - That s What Analysts Think Sangamo Therapeutics, Inc (NASDAQ:SGMO) Is Worth After These Results
yahoo.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from yahoo.com Daily Mail and Mail on Sunday newspapers.

Sangamo therapeuticsSangamo therapeutic

Sangamo Therapeutics (NASDAQ:SGMO) vs Scilex (NASDAQ:SCLX) Critical Review

Sangamo Therapeutics (NASDAQ:SGMO) vs Scilex (NASDAQ:SCLX) Critical Review
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United statesPalo altoSangamo biosciences incAldrich corporationScilex holding companyMonoclonal technology incBiogen ma incDow agrosciencesSangamo therapeutics incNovartis institutes for biomedical research incCalifornia institute for regenerative medicineGenentech incPfizer incKite pharma incShire international gmbGet free report

Critical Comparison: MeiraGTx (NASDAQ:MGTX) and Sangamo Therapeutics (NASDAQ:SGMO)

MeiraGTx (NASDAQ:MGTX – Get Free Report) and Sangamo Therapeutics (NASDAQ:SGMO – Get Free Report) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, risk, analyst recommendations, institutional ownership, dividends, valuation and profitability. Analyst Recommendations This is a summary of current […]

United statesNew yorkRoche incMonoclonal technology incRoche ltdGenentech incCalifornia institute for regenerative medicineSangamo therapeutics incAldrich corporationJanssen pharmaceuticals incDow agrosciencesSangamo biosciences incKite pharma incMeiragtx holdingsPfizer incNovartis institutes for biomedical research inc

MeiraGTx (NASDAQ:MGTX) and Sangamo Therapeutics (NASDAQ:SGMO) Head-To-Head Analysis

MeiraGTx (NASDAQ:MGTX – Get Free Report) and Sangamo Therapeutics (NASDAQ:SGMO – Get Free Report) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, earnings, dividends, institutional ownership, valuation, risk and profitability. Risk and Volatility MeiraGTx has a beta of […]

United statesNew yorkShire international gmbRoche ltdMonoclonal technology incGenentech incSangamo biosciences incJanssen pharmaceuticals incMeiragtx holdingsRoche incDow agrosciencesAldrich corporationNovartis institutes for biomedical research incCalifornia institute for regenerative medicineSangamo therapeutics incKite pharma inc

Q3 2023 EPS Estimates for Sangamo Therapeutics, Inc Decreased by HC Wainwright (NASDAQ:SGMO)

Sangamo Therapeutics, Inc. (NASDAQ:SGMO – Free Report) – Equities research analysts at HC Wainwright cut their Q3 2023 earnings per share (EPS) estimates for Sangamo Therapeutics in a note issued to investors on Monday, August 14th. HC Wainwright analyst P. Trucchio now anticipates that the biopharmaceutical company will earn ($0.38) per share for the quarter, […]

United statesStifel nicolausAcadian asset managementWells fargo companyBlackrock incSangamo therapeutics incSangamo therapeutics company profileVanguard group incSangamo therapeuticsFree reportSangamo therapeuticWells fargoAsset managementStreet corpVanguard groupGet free report